Author

D. Fuller

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metagenomics· 1 Organism:non-human primate· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Gustin· 1 shared A. Velez· 1 shared C. Basting· 1 shared C. C. Ward· 1 shared C. Driscoll· 1 shared C. Evandy· 1 shared C. M. Zammit· 1 shared C. Miller· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Gustin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Elevated peripheral and nervous system inflammation is associated with decreased short-chain fatty acid levels in Zika-virus infected macaques

C. Miller, J. Manuzak, A. Gustin, C. Basting, R. Cheu, T. Schroeder, A. Velez, C. Driscoll, J. Tisoncik-Go, L. Schifanella, T. Hensley-McBain, C. Evandy, E. Smith, D. Bratt, J. Smedley, , N. R. Klatt

This study links reduced short-chain fatty acid levels with elevated inflammation in Zika-virus infected macaques, suggesting microbial dysfunction contributes to CNS and systemic inflammation.

bioRxiv · Jul 25, 2023 · PreprintMicrobiology

Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors

P. Moon, L. Boike, D. Dovala, N. J. Henning, M. Knapp, J. N. Spradlin, C. C. Ward, H. Wolleb, C. M. Zammit, D. Fuller, G. Blake, J. P. Murphy, F. Wang, Y. Lu, S. A. Moquin, , D. K. Nomura

This study identifies and optimizes potent pyrazoline-based covalent inhibitors of SARS-CoV-2 Mpro, showing activity against multiple coronaviruses.

bioRxiv · Mar 5, 2022Biochemistry